Cytodyn Inc (CYDY)

[buckysherm]

The market is giving CYDY basically 0 % chance of passing FDA review. Why is that ? Is it still largely unnoticed ? The drying up of buying supports this.
Is there a circular logic in justifying CYDY share price ? As in: Pro-140 doesn't have a chance for approval because it would be reflected in the shares / mkt cap. The mkt cap is low because there's no chance of approval for Pro 140.
Or is it, "SHOW ME THE SCIENCE !!!" and after June 20, things will change.

Is the market hesitant to value CYDY because of upcoming dilution ?

Or does the market not value something until FDA actually does something ?

Or does the price fail to go up until BIG MONEY moves in ?
What we have seen so far is nothing. The total volume on the 10 biggest trading days this year is less than $10 Mill. Other companies with earlier trials have larger cap and larger volume trading.

Just wondering.